Great last 2 days at the SNMMI Dose Optimization in #RPTs workshop with the U.S. FDA. To facilitate combining dose-effect and clinical trial data collection, here's a template that can guide the development of those databases t.ly/f0CE3 t.ly/r4ICE

Amazing meeting put on by SNMMI to bring together industry, academia and the U.S. FDA. We had great collaborative discussions with our colleagues from the FDA Oncology and DIRM, which will help set the foundation for the future development of RLTs. bit.ly/3UPjPgd

Important study: more than 6 cycles of Lu-177 PSMA is both and safe and efficacious. For patients who benefited from initial cycles, there is an urgent need to enable global access to more cycles of effective treatment.

Big Pharma Player no 4 Enters the field of Radiotheranostics. Welcome Astra Zeneca! This is great for theranostics and nuclear medicine.
Johannes Czernin prof. Stefano Fanti Michael Hofman Jeremie Calais JNM astrazeneca.com/media-centre/p…

Our paper published:'Development of quantitative PET prostate phantom (Q3P) for improved quality assurance of 18F-PSMA PET imaging':
aapm.onlinelibrary.wiley.com/doi/10.1002/mp…
American Association of Physicists in Medicine Medical Physics; by Roberto Fedrigo. Now part of SNMMI Clinical Trials Network (CTN) Scanner Validation program!

Never underestimate the power of cooperation and collective action to save lives. Who are you and what will you do on 4 Feb? Speak up, stand up and take action together this #WorldCancerDay #CloseTheCareGap
worldcancerday.org
worldcancerday.org

1/2: People in BC are set to benefit from expanded access to lifesaving cancer diagnostics & increased provincial capacity for nuclear medicine-based care & disease research with a new state-of-the art cyclotron & radiopharmacy laboratories in Vancouver.
ow.ly/4E7a50Qw7kS

Really amazing turn out at the 2024 PSMA Conference. Sunglasses required when treating HOT tumors!

🎉 Wishing you all a Happy New Year filled with joy, success, and good health! 🌟 Here's to another year of advancements in #theranostics and patient care that is filled with innovation, compassion, and positive impact. Cheers to a fantastic 2024! 🥂 #HappyNewYear #Innovation

Future of medicine is unfolding before us.

Center for Virtual Imaging Trials (CVIT) #vitm24
How digital twins may enable personalised health treatment theguardian.com/science/2023/n…

Alisa Lattanzio likes being a PET/CT technologist because she makes a difference in people's lives. 'That's something I hold close to my heart,” she says. Read what inspired others to choose similar careers as we celebrate #MRTWeek2023 , at ow.ly/7lhL50Q69HY.

Congratulations to Dr. François Bénard, vice president of research at BC Cancer, who has won a Distinguished Service Award from the Western Region Society of Nuclear Medicine (WRSNM). Read more: ow.ly/2tMx50Q5MgY François Bénard SNMMI UBC Medicine

From X-rays to PET and CT scans to theranostics, learn how medical imaging for cancer care has evolved over the decades.

A tool that can help us perform better quantitative imaging for personalization of #theranostics procedures

Wow so cool 😎

Very encouraging results, first-in-human 225Ac-DOTATATE Dosimetry Results from Part 1 of the ACTION-1 Trial, presented by Dr Gary Ulaner on behalf of Dr Michael Morris.

Cassandra Miller proposing a method at the #eanm23 for dual isotope imaging in #RPTs for #prostatecancer that would allow identification of active bone marrow for dosimetry purposes.